The U.S. is showing signs of targeting China's domestic surveillance and the tech supporting it.Technologyread more
Pro-EU parties are set to hold onto two-thirds of the seats at the EU Parliament.Europe Politicsread more
The projected result comes shortly after Conservative Party leader Theresa May announced her resignation as prime minister on Friday morning.Europe Politicsread more
A Beijing decision to rapidly and sharply cut its excessive and unsustainable trade surplus with the U.S. would change for the better the bilateral relationship, writes...World Economyread more
Investors are largely focused on results of the EU parliamentary elections. Euroskeptic parties in Britain and France made solid gains.Europe Marketsread more
Former Apple CEO John Sculley says this skill is vital to all great business leadership.Successread more
Prime Minister Narendra Modi has to make sure that India becomes a highly competitive manufacturing hub where global investors will look to invest, the chairman of India...Asia Economyread more
U.S. President Donald Trump said Monday he expects to get the trade gap with Japan "straightened out rapidly," adding that announcements on that could come as soon as August.World Economyread more
Bitcoin surged more than 9% from the day before to hit its highest level in more than a year.Technologyread more
Stocks in Asia were mixed Monday afternoon as investors watched for developments from U.S. President Donald Trump's state visit to Japan as well as results from the European...Asia Marketsread more
Sources say the talks have picked up speed in recent days and could lead to an announcement regarding a merger or partnership by Monday.Autosread more
Johnson & Johnson is just the latest healthcare product company to face a wave of liability lawsuits.
Though it faces billions of dollars in claims alleging its talc baby powder products contained asbestos and caused cancer, the financial hit to the company has yet to be determined.
Johnson & Johnson stock plunged Friday following a report by Reuters that it knew for decades that its baby powder contained asbestos. The company released a statement calling the Reuters article "one-sided, false and inflammatory."
So far, some juries have sided with the company, which maintains that independent tests have shown the product does not contain asbestos. Other juries have been unable to reach verdicts.
In July, a Missouri jury ordered J&J to pay $4.69 billion in a case involving 22 women and their families. A judge affirmed the verdict in August and J&J vowed to appeal it.
Even if that verdict stands, the award would fall short of the biggest medical product liability case to date, which involved a diet pill, Fen-Phen, that was linked to potentially fatal heart problems.